where we’ve been, where we are, and where we’re going · where we’ve been, where we are, and...
TRANSCRIPT
Where we’ve been, where we are, and where we’re going
Jeff McDonaldDepartment of Molecular GeneticsUT Southwestern Medical Center
Dallas, TXLIPID MAPS “Glue Grant” NIH U54 GM 69338
Lipid analysis by multiple "omic" mass spectrometry platforms
Lipidome of Human Plasma
588
Lipids in Human Serum
Total cholesterol ~ 2 mg/mL
Trace oxysterols < 2 ng/mL
> 6 orders ofmagnitude
Triglycerides ~ 1 mg/mLPhospholipids ~ 2 mg/mLSphingolipids ~ 0.5 mg/mL
Cholesteryl ester
pg/mL mg/mLWikipedia : Reference ranges for blood tests - by mass.svg
Cholesterol
mg/mL
2) Base hydrolysis
Organic-soluble(lipids)
Insoluble material/proteins
200μL serum + standards
1) Solvent extraction (DCM/MeOH)
General Steps of Lipid Extraction and Purification
Aqueous (MeOH/H2O)
Organic (lipids) (DCM/MeOH)
3) Liquid-Liquid Extraction4) Solid phase extraction
KOH, 60°C
Condition With hexane
Load samplein hexane
Hexanerinse
Non polarlipids
Sterols +oxysterols
23:1CHCl3:MeOH
5) LC-MS
Mass Spectrometry
• Triple Quadrupole (MRM)• Neutral Loss Scan• Precursor Ion Scan
HPLC
• Normal Phase• Reverse Phase• HELIC
Analytical Separation and Detection of Lipids
Mass Spectrometry
• Electron Ionization• Electron-Capture Negative
Ionizationo Methane
GC
• DB5-MS 40m 0.18mm i.d.o H2 carrier gas
• DB5-MS 30m 0.25o He Carrier gas
Sterols/Oxysterol4 Samples4 Extractions2 LC-MS Analysis2 GC-MS Analysis
Prenols/Cardiolipins3 Samples1 Extraction3 LC-MS Analysis
Neutral Lipids3 Samples2 Extractions1 LC, 3 MS Analysis
Phospholipids2 Samples2 Extractions2 LC-MS Analysis
Human Plasma
Lipidome
Fatty Acids/Eicosanoids2 Samples2 Extractions1 LC-MS Analysis1 GC-MS Analysis
Sphingolipids1 Sample3 Extractions5 LC-MS Analysis
Summary15 Samples14 Extractions14 LC-MS methods3 GC-MS methods100’s standards7 Expert Centers$ Millions/many hours
Measurement of the Plasma Lipidome
The Workhorses of Lipid Analysis
AB Sciex Triple QuadrupoleMass Spectrometers Agilent GC-MS
Analytical Standards Generated by Avanti Polar Lipids
• >650 analytical lipid standards–300 new lipid standards–Primary, deuterated, odd-chain
• Purity and stability–Packaging, storage, shelf-life– In-house analytical expertise
Eicosanoids and Fatty Acids from Cayman Chemical
100+ eicosanoid
MS-Based Methods Developed by LM Cores
lipidmaps.org
A Ten-Year Timeline of Lipidomics
2003 2013
LIPID MAPS pioneers and advances speciated, quantitative LC/GC-MS methods for lipids
“Shotgun” Lipidomics introduced and implemented by Hann and Gross
Broad-scale, targeted and untargeted LC-MS “Omics” approaches flourishSuizdak, Fiehn, Sumner, Newgard, Roddy, etc
Advanced, infusion-based lipidomic methods introduced
Sterols
Sphingolipids
Phospholipids
Neutral Lipids
Prenols
Eicosanoids/Fatty Acids
One Sample, Many Choices
One Sample, Many Choices
“Ursus Analyticus” – Thanks Avanti!
Infusion-Based MS Platform for Lipidomic Analysis
Small moleculemetabolome
Insoluble material/proteins
20uL human plasma
1) Sample Extraction(CH2Cl2/MeOH)
LEAP Robotic Infusion System AB SCIEX TripleTOF 5600+ MS with SelexION
Workflow for Infusion-Based Global Lipidomics
B/D Extractionof plasma
Infuse into MS
Acquire TOF Spectrum
Acquire MS/MSALL
SpectrumData
Analysis
1 2 3 4 5
Workflow for Infusion-Based Global Lipidomics
B/D Extractionof plasma
Infuse into MS
Acquire TOF Spectrum
Acquire MS/MSALL
SpectrumData
Analysis
1 2 3 4 5
Plasma+StdsAqueous
Organic (lipids)
Workflow for Infusion-Based Global Lipidomics
B/D Extractionof plasma
Infuse into MS
Acquire TOF Spectrum
Acquire MS/MSALL
SpectrumData
Analysis
1 2 3 4 5
Workflow for Infusion-Based Global Lipidomics
B/D Extractionof plasma
Infuse into MS
Acquire TOF Spectrum
Acquire MS/MSALL
SpectrumData
Analysis
1 2 3 4 5
TOF SpectrumScan 200-1200 Da30-40K resolution< 2ppm mass accuracy
Cholesterol
CE
PC
TGPE
DG
SM
Workflow for Infusion-Based Global Lipidomics
B/D Extractionof plasma
Infuse into MS
Acquire TOF Spectrum
Acquire MS/MSALL
SpectrumData
Analysis
1 2 3 4 5
m/z 666CE 18:2
Workflow for Infusion-Based Global Lipidomics
B/D Extractionof plasma
Infuse into MS
Acquire TOF Spectrum
Acquire MS/MSALL
SpectrumData
Analysis
1 2 3 4 5
m/z 666CE 18:2Product-ion Spectrum
m/z 666m/z 369
m/z 666
Neutral Loss 379 = FA 18:2
Workflow for Infusion-Based Global Lipidomics
B/D Extractionof plasma
Infuse into MS
Acquire TOF Spectrum
Acquire MS/MSALL
SpectrumData
Analysis
1 2 3 4 5
Hour Time Scale
30 minutes 5 minutes
Mining the Dataset Post-Acquisition
Lipids that contain a 18:1 fatty acid (NL 281Da)
MS/MSALL identifies 800+ MS features
Lipids that contain a PE head group(NL 141 Da)
Lyso Phosphatidylethanolamine
Cholesteryl ester C18:1Triacylglycerol with FA 18:1
Lipids that contain a PC head group(Prec 184 Da) Lyso Phosphatidylcholines
Phosphatidylcholine
Phosphatidylethanolamine
PCA Analysis – MS/MSALL Data
Liver
Plasma
Blank
MarkerView (AB Sciex)
Can Infusion-Based Metabolomics be Quantitative?
LPC 18:0
C 36:2 DAG
TAG 54:3
The Future of Lipidomics
• Chromatograhic-based quantitative analysis– HPLC resolving power and efficiency– MS sensitivity– MS acquisition speed– Flexible, parallel acquisition
• Infusion-based analysis– Resolution, mass accuracy, linearity– Data analysis software– Off-line HPLC followed by infusion-based MS
• Ion-mobility• Accessibility to standards
– Class-specific mixtures (primary and internal)
Acknolwedgements
• LIPID MAPS community• Phil Sanders – Eli Lilly• Brigitte Simons – AB Sciex
– Jennifer Krone– Mark Cafazzo– Lyle Burton
• AB-Sciex Academic Partnership Program